Dr. Scott Rocklage is a well-known name is the business world. He attended the University of California, where he obtained his Bachelor of Science degree in Chemistry. He went on to study at the Massachusets Institute of Technology, and while he was studying there, he received his Ph.D. in Chemistry. Since leaving college, he has either invented or co-invented 30 United States Patents and has published over 100 different works.
Dr. Scott Rocklage has a long and varied career. He has held the position of Executive Chairman at Ilypsa, Miikana, and Semprus respectively. Dr. Rocklage currently serves as Board Chairman of the companies Rennovia, Kinestral, Epirus, Pulmatrix, and Cidara. Along with his several Chairman and Executive Chairman positions, he has worked in various R&D departments and held the title of President and CEO of Nycomed Salutar at one point in his career.
Dr. Scott Rocklage has over 30 United States patents in his portfolio that he has either created or co-created. While he was in college, he worked in the laboratory of Richard R. Schrock, who won the Nobel Prize in 2005 for his work in Chemistry. Dr. Rocklage has entered several other drugs into the clinical testing stage and has had three approved for use by the Food and Drug Administration and more information click here.
Dr. Rocklage joined 5AM Ventures in 2003 as a Venture Partner and became a Managing Partner in early 2004. He works within the company studying new areas of science, developing the company’s portfolio, and attending board meetings. Dr. Scott Rocklage works mainly with entrepreneurs who want to turn their ideas into new life-saving medications for people. He is currently focused on new cancer cell-targeting drugs, and the positive effect they can have on cancer patients and resume him.
Dr. Scott Rocklage has a bright career ahead of him and in dedicated to making the world a better place to live and learn more about Scott.